Catalytic autoantibodies in multiple sclerosis: Pathogenetic and clinical aspects

被引：0
|
作者：
V. K. Misikov
M. V. Kimova
O. M. Durova
A. G. Gabibov
S. V. Suchkov
I. I. Vorob’ev
N. A. Ponomarenko
机构：
[1] M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry,
[2] Moscow Regional Research and Clinical Institute,undefined
来源：
Bulletin of Experimental Biology and Medicine | 2005年 / 139卷
关键词：
multiple sclerosis; catalytic autoantibodies; abzymes; protoabzymes; DNA abzymes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The significance of catalytic autoantibodies abzymes in the pathogenesis of multiple sclerosis was evaluated in patients with different disease patterns and severity of disability.
引用
收藏
页码：85 / 88
页数：3
相关论文
共 50 条
  • [1] Catalytic autoantibodies in multiple sclerosis: Pathogenetic and clinical aspects
    Misikov, VK
    Kimova, MV
    Durova, OM
    Gabibov, AG
    Suchkov, SV
    Vorob'ev, II
    Ponomarenko, NA
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 139 (01) : 85 - 88
  • [2] Catalytic autoantibodies in autoimmune myocarditis: Clinical and pathogenetic implications
    Kolinina, EV
    Ponomarenko, NA
    Durova, OM
    Paleev, E
    Vorobyev, II
    Kekenadze, NN
    Shogenov, ZS
    Zemtsova, ME
    Gnuchev, NV
    Gabibov, AG
    Suchkov, SV
    TERAPEVTICHESKII ARKHIV, 2005, 77 (09) : 65 - 70
  • [3] Catalytic autoantibodies and their value in multiple sclerosis
    Suchkov, S
    Mysikov, V
    Panteleeva, E
    Durova, O
    Ponomorenko, O
    Gabibov, A
    Vorobyev, GI
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S166 - S166
  • [4] On the catalytic activity of autoantibodies in multiple sclerosis
    Ponomarenko N.A.
    Durova O.M.
    Vorob'ev I.I.
    Suchkov S.V.
    Gabibov A.G.
    Doklady Biochemistry and Biophysics, 2004, 395 (1-6) : 120 - 123
  • [5] Multiple sclerosis with early onset: pathogenetic, clinical characteristics, possibility of pathogenetic treatment
    Maslova, OI
    Bykova, OV
    Guseva, MR
    Sidorenko, EI
    Boiko, SY
    Sudomoina, MV
    Studenikin, V
    Shchelkovsky, VI
    Favorova, OO
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2002, : 46 - 51
  • [6] Multiple sclerosis: clinical aspects
    Oh, Jiwon
    Vidal-Jordana, Angela
    Montalban, Xavier
    CURRENT OPINION IN NEUROLOGY, 2018, 31 (06) : 752 - 759
  • [7] Vascular proliferation and angiogenesis in multiple sclerosis: Clinical and pathogenetic implications
    Ludwin, SK
    Henry, JM
    McFarland, H
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 505 - 505
  • [8] Clinical aspects of fatigue in multiple sclerosis
    Bergamaschi, R
    Romani, A
    Versino, M
    Poli, R
    Cosi, V
    FUNCTIONAL NEUROLOGY, 1997, 12 (05) : 247 - 251
  • [9] CLINICAL ASPECTS OF MULTIPLE-SCLEROSIS
    POSER, S
    NERVENHEILKUNDE, 1984, 3 (02) : 53 - 58
  • [10] Multiple sclerosis and autoantibodies
    Comez Ilmaz, N.
    Turkoglu, R.
    Orken, C.
    Gencer, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S66 - S67
12345